MPDL3280A (atezolizumab)

atezolizumab · Genentech

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MPDL3280A (atezolizumab), covering 2017-06-22 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: MPDL3280A With Chemoradiation for Lung Cancer [Phase 2]